Pharmacokinetics of digoxin: comparison of a two- and a three-compartment model in man. 1974

W G Kramer, and R P Lewis, and T C Cobb, and W F Forester, and J A Visconti, and L A Wanke, and H G Boxenbaum, and R H Reuning

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

W G Kramer, and R P Lewis, and T C Cobb, and W F Forester, and J A Visconti, and L A Wanke, and H G Boxenbaum, and R H Reuning
January 1975, Acta cardiologica,
W G Kramer, and R P Lewis, and T C Cobb, and W F Forester, and J A Visconti, and L A Wanke, and H G Boxenbaum, and R H Reuning
January 1982, Substance and alcohol actions/misuse,
W G Kramer, and R P Lewis, and T C Cobb, and W F Forester, and J A Visconti, and L A Wanke, and H G Boxenbaum, and R H Reuning
January 1980, Arzneimittel-Forschung,
W G Kramer, and R P Lewis, and T C Cobb, and W F Forester, and J A Visconti, and L A Wanke, and H G Boxenbaum, and R H Reuning
January 2001, Clinical pharmacokinetics,
W G Kramer, and R P Lewis, and T C Cobb, and W F Forester, and J A Visconti, and L A Wanke, and H G Boxenbaum, and R H Reuning
April 1980, Anesthesiology,
W G Kramer, and R P Lewis, and T C Cobb, and W F Forester, and J A Visconti, and L A Wanke, and H G Boxenbaum, and R H Reuning
April 1980, Anesthesiology,
W G Kramer, and R P Lewis, and T C Cobb, and W F Forester, and J A Visconti, and L A Wanke, and H G Boxenbaum, and R H Reuning
July 1982, Anesthesia and analgesia,
W G Kramer, and R P Lewis, and T C Cobb, and W F Forester, and J A Visconti, and L A Wanke, and H G Boxenbaum, and R H Reuning
October 1986, Journal of pharmacobio-dynamics,
W G Kramer, and R P Lewis, and T C Cobb, and W F Forester, and J A Visconti, and L A Wanke, and H G Boxenbaum, and R H Reuning
January 1976, Journal of clinical pharmacology,
W G Kramer, and R P Lewis, and T C Cobb, and W F Forester, and J A Visconti, and L A Wanke, and H G Boxenbaum, and R H Reuning
May 1999, Biological psychiatry,
Copied contents to your clipboard!